Schroder Investment Management Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
10,228
-2,820
| -22% | -$388K | ﹤0.01% | 959 |
|
|
2025
Q1 | $2.4M | Buy |
13,048
+441
| +3% | +$81.1K | ﹤0.01% | 886 |
|
|
2024
Q4 | $2.01M | Hold |
12,607
| – | – | ﹤0.01% | 922 |
|
|
2024
Q3 | $2.23M | Sell |
12,607
-27,773
| -69% | -$4.92M | ﹤0.01% | 925 |
|
|
2024
Q2 | $7.42M | Buy |
40,380
+896
| +2% | +$165K | 0.01% | 696 |
|
|
2024
Q1 | $7.03M | Sell |
39,484
-35,461
| -47% | -$6.31M | 0.01% | 720 |
|
|
2023
Q4 | $9.3M | Buy |
+74,945
| New | +$9.3M | 0.01% | 644 |
|